Combination with p300/CBP inhibitors, in particular the clinical compound CCS1477, was investigated the effect by Incucyte® S3 live-cell imaging in four different NUT carcinoma cell lines (Fig. 3b). Here, CREBBP is linked to nut midline carcinoma.